vs

Side-by-side financial comparison of CRACKER BARREL OLD COUNTRY STORE, INC (CBRL) and DENTSPLY SIRONA Inc. (XRAY). Click either name above to swap in a different company.

DENTSPLY SIRONA Inc. is the larger business by last-quarter revenue ($961.0M vs $797.2M, roughly 1.2× CRACKER BARREL OLD COUNTRY STORE, INC). CRACKER BARREL OLD COUNTRY STORE, INC runs the higher net margin — -3.1% vs -15.2%, a 12.1% gap on every dollar of revenue. On growth, DENTSPLY SIRONA Inc. posted the faster year-over-year revenue change (6.2% vs -10.9%). DENTSPLY SIRONA Inc. produced more free cash flow last quarter ($60.0M vs $-88.9M). Over the past eight quarters, DENTSPLY SIRONA Inc.'s revenue compounded faster (0.4% CAGR vs -2.4%).

Cracker Barrel Old Country Store, Inc., doing business as Cracker Barrel, is an American chain of restaurant and gift stores with a Southern country theme. The company's headquarters are in Lebanon, Tennessee, where Cracker Barrel was founded by Dan Evins and Tommy Lowe in 1969. The chain's early locations were positioned near Interstate Highway exits in the Southeastern and Midwestern United States, but expanded across the country during the 1990s and 2000s. As of August 10, 2023, the compan...

Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million.

CBRL vs XRAY — Head-to-Head

Bigger by revenue
XRAY
XRAY
1.2× larger
XRAY
$961.0M
$797.2M
CBRL
Growing faster (revenue YoY)
XRAY
XRAY
+17.1% gap
XRAY
6.2%
-10.9%
CBRL
Higher net margin
CBRL
CBRL
12.1% more per $
CBRL
-3.1%
-15.2%
XRAY
More free cash flow
XRAY
XRAY
$148.9M more FCF
XRAY
$60.0M
$-88.9M
CBRL
Faster 2-yr revenue CAGR
XRAY
XRAY
Annualised
XRAY
0.4%
-2.4%
CBRL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CBRL
CBRL
XRAY
XRAY
Revenue
$797.2M
$961.0M
Net Profit
$-24.6M
$-146.0M
Gross Margin
68.8%
46.1%
Operating Margin
-4.1%
-14.5%
Net Margin
-3.1%
-15.2%
Revenue YoY
-10.9%
6.2%
Net Profit YoY
-235.7%
66.0%
EPS (diluted)
$-1.10
$-0.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBRL
CBRL
XRAY
XRAY
Q4 25
$797.2M
$961.0M
Q3 25
$904.0M
Q2 25
$821.1M
$936.0M
Q1 25
$949.4M
$879.0M
Q4 24
$905.0M
Q3 24
$894.4M
$951.0M
Q2 24
$817.1M
$984.0M
Q1 24
$935.4M
$953.0M
Net Profit
CBRL
CBRL
XRAY
XRAY
Q4 25
$-24.6M
$-146.0M
Q3 25
$-427.0M
Q2 25
$12.6M
$-45.0M
Q1 25
$22.2M
$20.0M
Q4 24
$-430.0M
Q3 24
$18.1M
$-494.0M
Q2 24
$-9.2M
$-4.0M
Q1 24
$26.5M
$18.0M
Gross Margin
CBRL
CBRL
XRAY
XRAY
Q4 25
68.8%
46.1%
Q3 25
48.8%
Q2 25
69.9%
52.4%
Q1 25
67.4%
53.0%
Q4 24
49.3%
Q3 24
69.6%
52.1%
Q2 24
70.0%
51.9%
Q1 24
66.3%
53.1%
Operating Margin
CBRL
CBRL
XRAY
XRAY
Q4 25
-4.1%
-14.5%
Q3 25
-24.1%
Q2 25
1.8%
-13.7%
Q1 25
3.1%
7.2%
Q4 24
-56.2%
Q3 24
2.5%
-48.6%
Q2 24
-2.4%
5.1%
Q1 24
3.3%
4.4%
Net Margin
CBRL
CBRL
XRAY
XRAY
Q4 25
-3.1%
-15.2%
Q3 25
-47.2%
Q2 25
1.5%
-4.8%
Q1 25
2.3%
2.3%
Q4 24
-47.5%
Q3 24
2.0%
-51.9%
Q2 24
-1.1%
-0.4%
Q1 24
2.8%
1.9%
EPS (diluted)
CBRL
CBRL
XRAY
XRAY
Q4 25
$-1.10
$-0.74
Q3 25
$-2.14
Q2 25
$0.56
$-0.22
Q1 25
$0.99
$0.10
Q4 24
$-2.09
Q3 24
$0.80
$-2.46
Q2 24
$-0.41
$-0.02
Q1 24
$1.19
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBRL
CBRL
XRAY
XRAY
Cash + ST InvestmentsLiquidity on hand
$8.9M
$326.0M
Total DebtLower is stronger
$2.3B
Stockholders' EquityBook value
$428.8M
$1.3B
Total Assets
$2.2B
$5.4B
Debt / EquityLower = less leverage
1.70×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBRL
CBRL
XRAY
XRAY
Q4 25
$8.9M
$326.0M
Q3 25
$363.0M
Q2 25
$9.8M
$359.0M
Q1 25
$10.3M
$398.0M
Q4 24
$272.0M
Q3 24
$12.0M
$296.0M
Q2 24
$11.9M
$279.0M
Q1 24
$12.6M
$291.0M
Total Debt
CBRL
CBRL
XRAY
XRAY
Q4 25
$2.3B
Q3 25
Q2 25
Q1 25
Q4 24
$1.7B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CBRL
CBRL
XRAY
XRAY
Q4 25
$428.8M
$1.3B
Q3 25
$1.5B
Q2 25
$469.3M
$2.0B
Q1 25
$460.9M
$2.0B
Q4 24
$1.9B
Q3 24
$440.1M
$2.5B
Q2 24
$426.6M
$3.1B
Q1 24
$462.0M
$3.3B
Total Assets
CBRL
CBRL
XRAY
XRAY
Q4 25
$2.2B
$5.4B
Q3 25
$5.7B
Q2 25
$2.1B
$6.1B
Q1 25
$2.1B
$6.0B
Q4 24
$5.8B
Q3 24
$2.2B
$6.6B
Q2 24
$2.2B
$6.9B
Q1 24
$2.2B
$7.1B
Debt / Equity
CBRL
CBRL
XRAY
XRAY
Q4 25
1.70×
Q3 25
Q2 25
Q1 25
Q4 24
0.90×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBRL
CBRL
XRAY
XRAY
Operating Cash FlowLast quarter
$-53.4M
$101.0M
Free Cash FlowOCF − Capex
$-88.9M
$60.0M
FCF MarginFCF / Revenue
-11.2%
6.2%
Capex IntensityCapex / Revenue
4.5%
4.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$104.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBRL
CBRL
XRAY
XRAY
Q4 25
$-53.4M
$101.0M
Q3 25
$79.0M
Q2 25
$23.0M
$48.0M
Q1 25
$7.0M
Q4 24
$87.0M
Q3 24
$69.5M
$141.0M
Q2 24
$37.6M
$208.0M
Q1 24
$77.7M
$25.0M
Free Cash Flow
CBRL
CBRL
XRAY
XRAY
Q4 25
$-88.9M
$60.0M
Q3 25
$40.0M
Q2 25
$-13.6M
$16.0M
Q1 25
$-12.0M
Q4 24
$36.0M
Q3 24
$22.1M
$98.0M
Q2 24
$8.2M
$156.0M
Q1 24
$50.9M
$-9.0M
FCF Margin
CBRL
CBRL
XRAY
XRAY
Q4 25
-11.2%
6.2%
Q3 25
4.4%
Q2 25
-1.7%
1.7%
Q1 25
-1.4%
Q4 24
4.0%
Q3 24
2.5%
10.3%
Q2 24
1.0%
15.9%
Q1 24
5.4%
-0.9%
Capex Intensity
CBRL
CBRL
XRAY
XRAY
Q4 25
4.5%
4.3%
Q3 25
4.3%
Q2 25
4.5%
3.4%
Q1 25
2.2%
Q4 24
5.6%
Q3 24
5.3%
4.5%
Q2 24
3.6%
5.3%
Q1 24
2.9%
3.6%
Cash Conversion
CBRL
CBRL
XRAY
XRAY
Q4 25
Q3 25
Q2 25
1.83×
Q1 25
0.35×
Q4 24
Q3 24
3.83×
Q2 24
Q1 24
2.93×
1.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBRL
CBRL

Restaurant$650.6M82%
Retail$146.6M18%

XRAY
XRAY

Essential Dental Solutions$372.0M39%
Equipment And Instruments$160.0M17%
Implants And Prosthetics$150.0M16%
CADCAM$139.0M14%
Wellspect Healthcare$88.0M9%
Orthodontics$52.0M5%

Related Comparisons